Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

26.66 USD -0.02 (-0.07%)
Official Closing Price Updated: 7:58 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,723,800
Open 26.15
Bid (Size) 26.60 (1)
Ask (Size) 26.66 (4)
Prev. Close 26.68
Today's Range 25.90 - 27.04
52wk Range 11.15 - 29.68
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
South Korea's MFDS Approves LUMIFY® Eye Drops
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that LUMIFY® (brimonidine tartrate ophthalmic solution 0.025%)... 
From PR Newswire
Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that two poster presentations will feature data on the new Bausch... 
From PR Newswire

Performance

YTD
+24.75%
+24.75%
1 Month
+32.11%
+32.11%
3 Month
+45.21%
+45.21%
6 Month
+56.36%
+56.36%
1 Year
-8.67%
-8.67%

More News

Read More
Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (perfluorohexyloctane)
From PR Newswire
Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery
From PR Newswire
Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference
From PR Newswire
Nicox’s Licensee Bausch + Lomb Launches VYZULTA in Mexico
From GlobeNewswire News Releases
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
From PR Newswire
Bausch Health To Reduce Debt By $275 Million
From PR Newswire
Interesting BHC Put And Call Options For March 19th
Tags Stocks
From Market News Video
Bausch Health downgraded to Neutral from Overweight at Piper Sandler
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
IBD Rating Upgrades: Bausch Health Flashes Improved Relative Price Strength
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.